ArticleClinical case reports2020

Pasireotide-induced hyperglycemia in a patient with Cushing's disease: Potential use of sodium-glucose cotransporter 2 inhibitor and glucagon-like peptide-1 receptor agonist for treatment.

Masato Shikata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.